首页> 外文期刊>Case Reports in Endocrinology >The Utility of Immunohistochemistry in Differentiating Metastatic Primary Squamous Cell Carcinoma of the Thyroid from a Primary Lung Squamous Cell Carcinoma
【24h】

The Utility of Immunohistochemistry in Differentiating Metastatic Primary Squamous Cell Carcinoma of the Thyroid from a Primary Lung Squamous Cell Carcinoma

机译:免疫组织化学在甲状腺鳞状细胞癌中区分甲状腺转移性原发性鳞状细胞癌中的效用

获取原文
           

摘要

Primary squamous cell carcinoma of the thyroid gland (PSCCTh) and anaplastic thyroid carcinoma with extensive squamous differentiation are rare entities which pose a diagnostic challenge in determining the primary site when presented as metastases. The difficulty in confirming a thyroid primary is further compounded by the aggressive nature of these tumours which frequently present at advanced stages. We present a case in which the patient presented with a thyroid mass and a lung mass simultaneously. The risk of misinterpreting the site of primary tumour as lung is greatly increased because squamous cell carcinoma of lung is much more common than its thyroid counterpart. This case highlights the effectiveness of PAX-8 stain in determining the primary site of tumour when squamous cell carcinoma is found in both lung and thyroid gland.
机译:甲状腺腺体(PSCCTH)的主要鳞状细胞癌和具有广泛鳞状分化的芳塑性甲状腺癌是罕见的实体,其在呈现为转移时确定初级部位时造成诊断挑战。通过这些肿瘤的侵略性,常见于高级阶段的肿瘤性质,进一步混合了确认甲状腺初级的困难。我们提出了一种病例,患者同时呈现甲状腺质量和肺部质量。由于肺部的肺细胞癌鳞状细胞癌比其甲状腺对应更常见,误解原发性肿瘤部位的风险大大增加。这种情况强调PAX-8污染在肺细胞癌中发现鳞状细胞癌时肿瘤的主要部位的有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号